Skip to main content
U.S. flag

An official website of the United States government

NIA posts temporary interim pay lines

Dr. Ken Santora
Kenneth SANTORA,
Director,
Division of Extramural Activities (DEA)
.

NIA and NIH received an appropriation through H.R. 6119 - Further Extending Government Funding Act, which was signed into law on Dec. 3, 2021, and provides continuing fiscal year 2022 appropriations to federal agencies through Feb. 18, 2022. Though final details of the NIH budget remain pending, NIA is issuing this updated interim funding guidance.

At this time, NIA is paying FY 2022 noncompeting awards at 90% of the committed level as shown in the Notice of Award. It is the expectation of NIA to restore these cuts made in noncompeting awards paid earlier in this fiscal year once a full appropriation is granted and if adequate funds are committed.

Note: This interim pay line is temporary until NIA receives its final budget.

What does this interim pay line mean for the general allocation?

NIA is reducing FY 2021 competing awards by 18% on average. This average cut policy applies to all research project awards except R03s (small grants), R21s (exploratory/developmental awards) and R15s (Academic Research Enhancement Awards and the NIH Research Enhancement Awards program). These awards (R03, R21, R15) generally receive the study-section-recommended amount of support. The 18% cut remains an average. Individual awards may be reduced by more or less than that percentage.

And now for the Alzheimer’s allocation

NIA is paying awards at their full study-section-recommended amounts unless concerns about overlap or similar issues reduce the amount awarded.

See below for full details:

CSR-reviewed Research Applications (Percentile Based)
Applications General pay line, < $500k General pay line, ≥ $500k AD/ADRD pay line
All (except below) 8% 5% 25%
New Investigator R01s 11% 8% 28%
Early-Stage Investigator R01s 13% 10% 30%

Though NIA expects to pay most applications within these lines, when scientific concerns are identified in peer review that weaken the case for making an award, we may alternatively provide short-term support (R56) or invite a resubmission of the application. Similarly, we may pay a few applications beyond the pay lines when they focus on the high priorities of the institute.

NIA-reviewed Research Applications (Overall Impact Score Based)
Applications General pay line AD/ADRD pay line
Program projects 13 37
Other NIA-reviewed research 13 37
Parent career development awards 18 28
Parent fellowship awards 25 28

Though NIA expects to pay most applications within these lines, when scientific concerns are identified in peer review that weaken the case for making an award, we may invite a resubmission of the application. Similarly, we may pay a few applications beyond the pay lines when they focus on the high priorities of the institute.

All other categories of awards (Conference, Institutional Training, Small Business) are allocation-based rather than based on a funding line.

Stay in touch for more information

For more information, please visit NIA’s temporary FY 2022 interim pay lines webpage.

If you have concerns or questions about applications already submitted, it is important to connect with the program officer (PO) who will understand your research area. Visit NIA’s staff listing or the appropriate NIA research division to learn more about each PO and find your best contact.

As we have more budget news to share, we’ll do our best to keep you informed. Please stay in touch by signing up for our blog, funding news, and training and career development email Listservs!

Add new comment

Your e-mail address will not be posted.

Plain text

  • Allowed HTML tags: <p> <br>
  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

nia.nih.gov

An official website of the National Institutes of Health